Randomized clinical trials are not always the best way to assess diagnostic tests: the case of fetal fibronectin testing.

Am J Obstet Gynecol

Department of Obstetrics and Gynecology, Robinson Institute, School of Medicine, University of Adelaide, Adelaide, Australia.

Published: January 2018

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.ajog.2017.10.037	DOI Listing

Publication Analysis

randomized clinical

clinical trials

trials best

best assess

assess diagnostic

diagnostic tests

tests case

case fetal

fetal fibronectin

fibronectin testing

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!